|
| 37872454 | Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients. | Ann Surg Oncol | 2024 |
| 37878154 | Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer. | Breast Cancer Res Treat | 2024 |
| 36305029 | Response Rates of Invasive Lobular Cancer in Patients Undergoing Neoadjuvant Endocrine or Chemotherapy. | Am Surg | 2023 |
| 37714645 | Lasting Impacts of the COVID-19 Pandemic on Breast Cancer Diagnosis and Treatment in the United States. | Surg Oncol Clin N Am | 2023 |
| 37488395 | ASO Author Reflections: Low Estrogen Receptor (ER) Expression Breast Cancer Behaves More like ER Negative Disease and Influences Management. | Ann Surg Oncol | 2023 |
| 37707811 | Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical Trial. | JAMA Netw Open | 2023 |
| 37589839 | Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes. | Breast Cancer Res Treat | 2023 |
| 37516725 | ASO Visual Abstract: Clinical Behavior, Management, and Treatment Response of Estrogen Receptor-Low (1-10%) Breast Cancer. | Ann Surg Oncol | 2023 |
| 37615191 | Lessons learned from the COVID-19 pandemic: Using telemedicine for pre-operative surgical evaluation in breast disease. | J Telemed Telecare | 2023 |
| 37696281 | Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial. | Lancet Oncol | 2023 |
| 37460743 | Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer. | Ann Surg Oncol | 2023 |
| 37325931 | Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial. | Ann Surg | 2023 |
| 36993608 | Clinical Outcomes and Prognostic Factors in Triple-Negative Invasive Lobular Carcinoma of the Breast. | Res Sq | 2023 |
| 37251618 | Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective registry data. | Clin Transl Radiat Oncol | 2023 |
| 37380911 | Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial. | Ann Surg Oncol | 2023 |
| 37210429 | Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast. | Breast Cancer Res Treat | 2023 |
| 37244627 | Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported Outcomes. | Int J Radiat Oncol Biol Phys | 2023 |
| 36977292 | Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). | J Clin Oncol | 2023 |
| 37277309 | First steps into synoptic operative reporting in breast cancer surgery: A journey to improve quality cancer care. | Surgery | 2023 |
| 37072398 | Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer. | Nat Commun | 2023 |
| 36971986 | Reply to: "The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial: A Comment" by Alser, Osaid. | Ann Surg Oncol | 2023 |
| 37226243 | Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors. | Breast Cancer Res | 2023 |
| 36653664 | Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer. | Ann Surg Oncol | 2023 |
| 36808041 | Outcomes of robotic nipple-sparing mastectomy versus conventional nipple-sparing mastectomy in women with breast cancer: a systematic review and meta-analysis. | J Robot Surg | 2023 |
| 36745260 | ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer. | Ann Surg Oncol | 2023 |
| 36689092 | Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study. | Breast Cancer Res Treat | 2023 |
| 36469363 | Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast Cancer. | Cancer Res | 2023 |
| 33160859 | MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. | Acad Radiol | 2022 |
| 35734391 | Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response. | NAR Cancer | 2022 |
| 35609361 | National Cancer Database trends in surgical resection of the breast primary for stage IV breast cancer. | Surg Oncol | 2022 |
| 35834142 | Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer. | Ann Surg Oncol | 2022 |
| 35578060 | The EA2108 Clinical Trial and Real-World Data: A Cautionary Tale in Stage IV Breast Cancer. | Ann Surg Oncol | 2022 |
| 35832147 | Postmastectomy Breast Reconstruction is Safe in Patients on Chronic Anticoagulation. | Arch Plast Surg | 2022 |
| 35794363 | ASO Author Reflections: In an Era of De-escalation, Are We Still Doing Too Much for Stage 0 Breast Cancer? | Ann Surg Oncol | 2022 |
| 35789303 | Overuse of Axillary Surgery in Patients with Ductal Carcinoma In Situ: Opportunity for De-escalation. | Ann Surg Oncol | 2022 |
| 35854027 | Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes. | Ann Surg Oncol | 2022 |
| 35569077 | Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer: Effects of Age and Tumor Ki67. | Ann Surg Oncol | 2022 |
| 35486168 | Ultrasound high-definition microvasculature imaging with novel quantitative biomarkers improves breast cancer detection accuracy. | Eur Radiol | 2022 |
| 35451727 | Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database. | Ann Surg Oncol | 2022 |
| 35713802 | Surveillance mammography after treatment for male breast cancer. | Breast Cancer Res Treat | 2022 |
| 35385996 | Sexual Well-Being After Nipple-Sparing Mastectomy: Does Preservation of the Nipple Matter? | Ann Surg Oncol | 2022 |
| 35776260 | ASO Visual Abstract: Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer-Effects of Age and Tumor Ki67. | Ann Surg Oncol | 2022 |
| 35849283 | Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma. | Ann Surg Oncol | 2022 |
| 36554065 | Current Considerations in Surgical Treatment for Adolescents and Young Women with Breast Cancer. | Healthcare (Basel) | 2022 |
| 36458203 | Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer. | Mol Ther Oncolytics | 2022 |
| 36456573 | Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer. | NPJ Breast Cancer | 2022 |
| 36109410 | ASO Visual Abstract: Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes. | Ann Surg Oncol | 2022 |
| 35871670 | ASO Visual Abstract: Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk. | Ann Surg Oncol | 2022 |
| 35870053 | ASO Visual Abstract: Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma. | Ann Surg Oncol | 2022 |
| 36069821 | Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial. | JAMA Surg | 2022 |